OCEAN Dx
OCEAN Dx is a company dedicated to revolutionizing infectious disease diagnostics, especially sepsis, by offering rapid, sensitive, and broad-spectrum diagnostic tests. Their goal is to save lives by delivering results in less than 5 hours and to improve antimicrobial management to prevent drug resistance.
Industries
Nr. of Employees
small (1-50)
OCEAN Dx
11 Avenue de Canteranne, Bâtiment PLEIONE, 33600 Pessac, France
Products
Ultra-fast sepsis diagnostic test (prototype)
A prototype in vitro diagnostic test designed to identify bloodstream infection-causing pathogens from whole blood with a panel covering approximately 600 bacterial species, delivering results in under 5 hours and demonstrating a reported analytical limit of detection near 2 cells/mL from up to 9 mL of whole blood.
Ultra-fast sepsis diagnostic test (prototype)
A prototype in vitro diagnostic test designed to identify bloodstream infection-causing pathogens from whole blood with a panel covering approximately 600 bacterial species, delivering results in under 5 hours and demonstrating a reported analytical limit of detection near 2 cells/mL from up to 9 mL of whole blood.
Services
On-site clinical study collaboration to evaluate diagnostic prototype performance in patients with suspected sepsis (example: planned/ongoing study on clinical patients to assess prototype).
In-house development and automation of an ultra-fast in vitro diagnostic pre-industrial prototype, including scale-to-prototype activities supported by public grants.
On-site clinical study collaboration to evaluate diagnostic prototype performance in patients with suspected sepsis (example: planned/ongoing study on clinical patients to assess prototype).
In-house development and automation of an ultra-fast in vitro diagnostic pre-industrial prototype, including scale-to-prototype activities supported by public grants.
Expertise Areas
- In vitro diagnostics for infectious diseases
- Sepsis diagnostics
- Assay development and multiplex panel design
- High-sensitivity detection from whole blood
Key Technologies
- Multiplex molecular diagnostics
- High-sensitivity nucleic-acid-based detection
- Whole-blood sample processing
- Automated diagnostic workflow integration
News & Updates
The clinical study on 110 patients conducted in collaboration with Bordeaux University Hospital aims to evaluate the performance of OCEAN Dx's prototype for rapid sepsis diagnosis.
OCEAN Dx announced the closure of its initial fundraising round from Bpifrance and business angels to support its development.
OCEAN Dx, a Bordeaux-based startup, won the i-Nov 2020 contest organized by the French General Secretary for Investment, with a prize of €400,000.
OCEAN Dx, specialized in infectious diseases diagnostics, won the i-Lab 2020 contest organized by the French Ministry of Higher Education, Research, and Innovation, with a prize of €250,000.
OCEAN Dx received €202,000 in non-dilutive funding from the Nouvelle-Aquitaine region to develop its first product prototype.
The clinical study on 110 patients conducted in collaboration with Bordeaux University Hospital aims to evaluate the performance of OCEAN Dx's prototype for rapid sepsis diagnosis.
OCEAN Dx announced the closure of its initial fundraising round from Bpifrance and business angels to support its development.
OCEAN Dx, a Bordeaux-based startup, won the i-Nov 2020 contest organized by the French General Secretary for Investment, with a prize of €400,000.
OCEAN Dx, specialized in infectious diseases diagnostics, won the i-Lab 2020 contest organized by the French Ministry of Higher Education, Research, and Innovation, with a prize of €250,000.
OCEAN Dx received €202,000 in non-dilutive funding from the Nouvelle-Aquitaine region to develop its first product prototype.